Publications
FEATURED PUBLICATION
Five powerful Ideas on KOL Network Management
Our Publications
- Filter by service
- Commercial Models
- Market Access
- Regulatory
- Marketing
- Sales
- Customer & Market Insights
- Network Mapping & MGT
The Pharmaceutical Executive, Global Digest December 2011
Many pharmaceutical companies still prefer to deal with their stakeholders one-by-one in a controlled way. They are often...
Read moreThe Pharmaceutical Executive Global Digest, November 2011
Market access has been a hot topic in pharma for several years now. But while most companies have made the leap to putting...
Read moreThe Burrill Report, October 2011
The drug reorganization act in Germany known as AMNOG places new requirements on pharmaceutical companies to provide justification...
Read morePharma Marketing Journal 06/2011
Auch in der Pharmabranche rückt der Kunden immer weiter in den Vordergrund. Aber von der formulierten zur tatsächlich umgesetzten...
Read morePharmaceutical Marketing E-Journal, March 2011
Dr. Hans-Joachim Diedenhofen and Klarissa Hoday show what industry can do to avoid the worst when dealing with AMNOG...
Read moreHandelsblatt, February 22nd 2011
Dr. Hans-Joachim Diedenhofen discusses the effects of AMNOG on the price of medicine in Germany and beyond (article in German)....
Read morePharmaceutical Marketing Europe, January/February 2011
Meike Wenzel and Klarissa Hoday describe the access challenges and the regulatory process in Germany...
Read morePharmaceutical Marketing Europe, January/February 2009
The article summarises the Swiss approval process and the interaction between doctors and industry in Switzerland ...
Read morePharmaceutical Executive Europe, December 2008
Paul Gardiner and Andrea Sobrio explain why most companies need ‘organisational polygamy’ to maximise profit and best...
Read morePharmaceutical Executive Europe, March 2008
The article looks at how changes to German healthcare regulation have created a need for effective go-to-market sales models....
Read moreJournal of Medical Marketing (2007), Vol. 7, 4
Using networks as a framework to understand the changing nature of the healthcare environment, the paper proposes a shift...
Read moreJournal of Medical Marketing (2007), Vol. 7, 2
Pharmaceutical companies need to find better ways of integrating into the healthcare network to address challenges such as...
Read morePharma Marketing Journal, 3/2007
Network analysis of healthcare professionals allow a company to move away from a fragmented perspective on individual doctors...
Read moreJournal of Medical Marketing (2007), Vol. 7, 1
The paper provides an organisational design framework and ideas of how companies can re-organise their commercial operations...
Read moreJournal of Medical Marketing (2006), Vol. 6, 4
A practical guide to understanding influence networks in the healthcare industry describing a systematic approach, explaining...
Read morePharma Relations, August 2006
A role-based segmentation can help to identify decision makers in pharma networks (article in German)....
Read moreJournal of Medical Marketing (2006), Vol. 6, 3
This article explains the concept of networked healthcare, demonstrate how the industry is becoming more networked and outline...
Read moreEuropean Pharmaceutical Executive, March/April 2006
Understanding the implications of an increasingly networked healthcare environment will help pharmaceutical companies to...
Read moreJournal of Medical Marketing (2005), Vol. 5, 4
With customer needs being more associated with their role than their profession, this article proposes an approach that can...
Read more